مقایسهٔ روشها
روشهای انتخابی خود را کنار هم مرور کنید؛ ردیفهای متفاوت برجسته شدهاند.
| مدلسازی فارماکودینامیک جمعیتی× | فارماکوکینتیک مبتنی بر فیزیولوژی× | |
|---|---|---|
| حوزه | داروشناسی | داروشناسی |
| خانواده | Process / pipeline | Process / pipeline |
| سال پیدایش≠ | 1992 | 1997 |
| پدیدآور≠ | Lewis Sheiner and Stephen Roush | Ivan Nestorov |
| نوع≠ | dose-response modeling | predictive modeling |
| منبع بنیادین≠ | Dahlström, B., & Nyberg, L. (1993). Population pharmacokinetics and pharmacodynamics. Clinical Pharmacokinetics, 24(1), 45-57. link ↗ | Nestorov, I. (1997). Sensitivity analysis of pharmacokinetic and pharmacodynamic systems. Journal of Pharmacokinetics and Biopharmaceutics, 25(4), 529-543. link ↗ |
| نامهای دیگر≠ | PopPD, population PD, hierarchical PD modeling | PBPK, PBPK modeling |
| مرتبط | 3 | 3 |
| خلاصه≠ | Population pharmacodynamic (PopPD) modeling integrates pharmacokinetics with individual dose-response relationships across patient populations to characterize drug efficacy and tolerability. Pioneered by Lewis Sheiner and colleagues, PopPD accounts for inter-individual variability in drug effects and enables rational dose optimization and response prediction. | PBPK is a mechanistic modeling framework that uses physiological parameters, tissue properties, and drug-specific attributes to predict drug concentration time profiles in the body. Developed rigorously in the 1990s by researchers including Nestorov, PBPK integrates anatomy, biochemistry, and kinetics to enable rational drug development, bridging in vitro data to clinical outcomes. |
| ScholarGateمجموعهداده ↗ |
|
|